Yes, of course.
The mandate of the committee that was struck in the United Kingdom was to study, first, dependence on prescription drugs, including psychotropics, and, second, how to support persons in withdrawal.
What we're seeing on the ground, particularly in the community sector, as you said, is that many young women and older people are prescribed antidepressants and anxiolytics without there being any monitoring of that medication or instructions as to when to stop taking it. Consequently, those drugs may be prescribed for years without the patient being advised on dosage reduction or withdrawal methods.
People are also very rarely informed, before they take certain drugs, about how difficult it is to withdraw from them. We've observed that inadequate information is provided when drugs are prescribed. Even health professionals aren't always well equipped to ensure that withdrawal is done properly. That has been studied in the United Kingdom, and we think we should examine that particular issue in Canada too.